Xuening Li Selected Research

AZD5153

1/2020

Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuening Li Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2016
3	Body Weight (Weight, Body) 01/2023 - 01/2022
3	Infections 01/2022 - 12/2013
2	Dyslipidemias (Dyslipidemia) 09/2021 - 01/2021
1	Inflammation (Inflammations) 01/2024
1	Infarction (Infarctions) 01/2024
1	Cerebral Infarction 01/2024
1	Pediatric Obesity 11/2023
1	Fetal Weight 10/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Dizziness (Lightheadedness) 01/2023
1	Headache (Headaches) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023
1	Hypertriglyceridemia 01/2023
1	Parkinson Disease (Parkinson's Disease) 10/2022
1	Parkinsonian Disorders (Parkinsonism) 10/2022
1	Disease Progression 10/2022
1	Necrosis 05/2022
1	Ischemic Stroke 02/2022
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Hemorrhage 01/2022
1	Osteoporosis 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Birth Weight (Birth Weights) 09/2021
1	Embolic Stroke 08/2021
1	Stroke (Strokes) 08/2021
1	Hypothyroidism 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
2	LeptinIBA 11/2023 - 09/2021
2	tirzepatideIBA 01/2023 - 01/2022
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2023 - 01/2022
2	Insulin (Novolin)FDA Link 01/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2015
2	LipidsIBA 09/2021 - 01/2021
2	GlucokinaseIBA 01/2017 - 01/2016
2	DorzagliatinIBA 01/2017 - 01/2016
1	fibrin fragment D (D-dimer)IBA 01/2024
1	Choline (Choline Chloride)IBA 10/2023
1	Dietary ProteinsIBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	EstersIBA 01/2023
1	Fibrinogen (Factor I)FDA Link 01/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Liraglutide FDA Link 01/2023
1	eicosapentaenoic acid ethyl esterIBA 01/2023
1	Eicosapentaenoic AcidIBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	SaponinsIBA 05/2022
1	Uric Acid (Urate)IBA 02/2022
1	CarbohydratesIBA 01/2022
1	semaglutideIBA 01/2022
1	dulaglutideIBA 01/2022
1	alirocumabIBA 01/2022
1	insulin degludecIBA 01/2022
1	evolocumabIBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	Insulin Glargine (Lantus)FDA Link 01/2022
1	Denosumab FDA Link 01/2022
1	RivaroxabanIBA 01/2022
1	Proprotein Convertase 9IBA 01/2022
1	SugammadexIBA 01/2022
1	Sunitinib (Sutent)FDA Link 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Biological FactorsIBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	LactoferrinIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	Acarbose FDA LinkGeneric 01/2022
1	Biosimilar PharmaceuticalsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	Cholesterol Ester Transfer ProteinsIBA 01/2021
1	anacetrapibIBA 01/2021
1	Thyroid HormonesIBA 01/2020
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2020
1	molibresibIBA 01/2020
1	mivebresibIBA 01/2020
1	Thyrotropin Alfa FDA LinkGeneric 01/2020
1	PLX51107IBA 01/2020
1	INCB054329IBA 01/2020
1	CPI-0610IBA 01/2020
1	Iodine-131IBA 01/2020
1	AZD5153IBA 01/2020
1	ODM-207IBA 01/2020
1	INCB057643IBA 01/2020

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2022
1	Drug Therapy (Chemotherapy) 01/2023
1	Adjuvant Chemotherapy 01/2023
1	Exercise Therapy (Therapy, Exercise) 10/2022